Why the study?
Does oxidative stress by GSH oxidation increase proarrhythmic vulnerability in a guinea pig model of chronic hyperglycemia, and is it reversible by insulin?
Does oxidative stress by GSH oxidation increase proarrhythmic vulnerability in a guinea pig model of chronic hyperglycemia, and is it reversible by insulin?
In a guinea pig model of chronic hyperglycemia, oxidative stress unmasks proarrhythmic vulnerability that is not reversed by insulin-mediated glycemic control, highlighting the potential need for antioxidant therapies.
Answers are grounded in this paper and cite their sources.
Oxidative stress may drive arrhythmia vulnerability beyond glycemic control in hyperglycemia models; leaves open whether antioxidant therapies warrant clinical investigation.
Chronic hyperglycemia in type-1 diabetes mellitus is associated with oxidative stress (OS) and sudden death. Mechanistic links remain unclear. We investigated changes in electrophysiological (EP) properties in a model of chronic hyperglycemia before and after challenge with OS by GSH oxidation and tested reversibility of EP remodeling by insulin. Guinea pigs survived for 1 mo following streptozotocin (STZ) or saline (sham) injection. A treatment group received daily insulin for 2 wk to reverse STZ-induced hyperglycemia (STZ + Ins). EP properties were measured using high-resolution optical action potential mapping before and after challenge of hearts with diamide. Despite elevation of glucose levels in STZ compared with sham-operated (P = 0.004) and STZ + Ins (P = 0.002) animals, average action potential duration (APD) and arrhythmia propensity were not altered at baseline. Diamide promoted early (<10 min) formation of arrhythmic triggers reflected by a higher arrhythmia scoring index in STZ (P = 0.045) and STZ + Ins (P = 0.033) hearts compared with sham-operated hearts. APD heterogeneity underwent a more pronounced increase in response to diamide in STZ and STZ + Ins hearts compared with sham-operated hearts. Within 30 min, diamide resulted in spontaneous incidence of ventricular tachycardia and ventricular fibrillation (VT/VF) in 3/6, 2/5, 1/5, and 0/4 STZ, STZ + Ins, sham-operated, and normal hearts, respectively. Hearts prone to VT/VF exhibited greater APD heterogeneity (P = 0.010) compared with their VT/VF-free counterparts. Finally, altered EP properties in STZ were not rescued by insulin. In conclusion, GSH oxidation enhances APD heterogeneity and increases arrhythmia scoring index in a guinea pig model of chronic hyperglycemia. Despite normalization of glycemic levels by insulin, these proarrhythmic properties are not reversed, suggesting the importance of targeting antioxidant defenses for arrhythmia suppression.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: